Functional and clinical aspects of the myelomonocyte protein calprotectin.
Johne
B
B
Nycomed Pharma AS, Oslo, Norway. berit.johne@nycomed.telemax.no
Fagerhol
M K
MK
Lyberg
T
T
Prydz
H
H
Brandtzaeg
P
P
Naess-Andresen
C F
CF
Dale
I
I
D000935:Antifungal Agents / Q000097:blood* / Q000737:chemistry; D015415:Biomarkers / Q000097:blood; D001826:Body Fluids / Q000737:chemistry; D002135:Calcium-Binding Proteins / Q000097:blood / Q000737:chemistry / Q000502:physiology*; D005767:Gastrointestinal Diseases / Q000175:diagnosis; D006801:Humans; D039841:Leukocyte L1 Antigen Complex; D009000:Monocytes / Q000378:metabolism; D019006:Neural Cell Adhesion Molecules / Q000097:blood / Q000737:chemistry / Q000502:physiology*; D012216:Rheumatic Diseases / Q000175:diagnosis*
D000935:Antifungal Agents; D015415:Biomarkers; D002135:Calcium-Binding Proteins; D039841:Leukocyte L1 Antigen Complex; D019006:Neural Cell Adhesion Molecules